β2-microglobulin has a different regulatory molecular mechanism between ER + and ER − breast cancer with HER2 −
2019
Background
Previous studies have demonstrated that β2-microglobulin (β2M) promotes the growth and survival of a variety of cancer cells and has different regulatory effects on the expression of Bcl-2 and HER2 in HER2− breast cancer cells. However, β2M-mediated signaling in ER+ and ER− breast cancer with HER2− remains unclear.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
40
References
3
Citations
NaN
KQI